Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Business Context and Reporting Period

This Form 8-K is a current report filed by Aureus Greenway Holdings Inc. on September 24, 2025. The filing primarily addresses corporate governance and equity compensation matters under Item 5.02, specifically the approval and issuance of stock options under the Company's 2025 Equity Incentive Plan.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on equity grants and does not contain financial performance data.

Material Changes and Equity Grants

On August 20, 2025, the Compensation Committee approved the grant of nonqualified stock options to directors, officers, employees, and consultants. The 2025 Equity Incentive Plan was approved by stockholders on August 13, 2025, and became effective on September 23, 2025. The options were issued on September 24, 2025, and vest immediately. The grants include:

  • Ching Ping Stephen Cheung (Chairman/Director): 750,000 options at $1.00/share and 550,000 options at $1.25/share.
  • ChiPing Cheung (CEO/Director): 60,000 options at $1.25/share.
  • KayHwa Tang (Former Director): 20,000 options at $1.25/share.
  • Joshua Tay (Former Director): 20,000 options at $1.25/share.
  • Xinyue Jasmine Geffner (Director): 20,000 options at $1.25/share.
  • Employees and Consultants: 60,000 options at $1.25/share.

Guidance, Outlook, and Risks

The filing contains no management commentary regarding future guidance, outlook, or specific risks. The only contingency noted is that the stock option grants were conditional upon the stockholder approval of the 2025 Equity Incentive Plan, which was satisfied on September 23, 2025.

Investor Verification Checklist

  • Verify the total number of shares authorized under the 2025 Equity Incentive Plan to assess dilution impact.
  • Confirm the current market price of Common Stock (AGH) relative to the exercise prices of $1.00 and $1.25.
  • Review the full text of the Stock Option Agreement (Exhibit 10.1) for specific vesting conditions or clawback provisions not detailed in the summary.
  • Check subsequent filings for any changes in the status of the directors listed as "then Director" (KayHwa Tang and Joshua Tay).
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.